Psoriasis (PsO)
34
16
20
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 34 trials
100.0%
+13.5% vs benchmark
15%
5 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (34)
A Study of HL40626S Tablets in Healthy Adults
The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
Global Healthcare Study on Psoriasis
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Inflammation Digital Biomarkers Validation Study
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Psoriasis Comorbidities at Hospital Calderón Guardia
Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults
A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)